1) Seratrodast Tablets
塞曲司特片
1.
Dissolution determination of Seratrodast Tablets by UV spectrophotography;
紫外分光光度法测定塞曲司特片的溶出度
2) seratrodast
塞曲司特
1.
The process for synthesizing seratrodast;
塞曲司特的合成工艺研究
2.
Pharmacokinetics and relative bioavailability of seratrodast granule in healthy volunteers;
塞曲司特颗粒的人体药代动力学和相对生物利用度
3.
Effectiveness and safety of Seratrodast,a thromboxane A_2 receptor antagonist,for asthma;
血栓素A_2受体拮抗剂塞曲司特治疗支气管哮喘疗效和安全性的研究
4) seratrodast granule
塞曲司特颗粒剂
1.
Pharmacokinetics and relative bioavailability of seratrodast granules in healthy volunteers;
塞曲司特颗粒剂的人体药代动力学和相对生物利用度
5) Compound Tranilast Tablets
复方曲尼司特片
1.
Determination of Salbutamol Sulfate in Compound Tranilast Tablets by RP-HPLC
RP-HPLC法测定复方曲尼司特片中硫酸沙丁胺醇的含量
6) tranilast
曲尼司特
1.
The effect of tranilast on Ang Ⅱ and ET-1 in the rats with chronic cyclosporine A nephrotoxicity;
曲尼司特对CsA慢性肾毒性大鼠AngⅡ和ET-1的影响
2.
Effects of tranilast on myocardial fibrosis and expression of TGF-β1 after myocardial infarction in rats;
曲尼司特对大鼠心肌梗塞后心肌纤维化及TGF-β1表达的影响
3.
Hepatic injury and hematuria resulting from tranilast;
曲尼司特致肝损害和血尿
补充资料：多塞特文化
见爱斯基摩文化。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条